Marius Ringelstein

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

Pain as a First Manifestation of Paraneoplastic Neuropathies: A Systematic Review and Meta-Analysis

Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder

A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1

Myasthenia Gravis

Diagnosis of multiple sclerosis: progress and challenges

Heritable and non-heritable uncommon causes of stroke

Autoantibodies and pain

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Herpesvirus-Associated Encephalitis: an Update

Neuromyelitis optica spectrum disorders associated with other autoimmune diseases

Aquaporin 4 and neuromyelitis optica

Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders

Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis

B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation

2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association

Evaluation of aquaporin‐4 antibody assays

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

The history of neuromyelitis optica

Aquaporin‐4 Antibodies (NMO‐IgG) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature

Multiple Sclerosis

Neuropathic Pain: From Mechanisms to Treatment

Autonomic Dysregulation, Cognitive Impairment, and Symptoms of Psychosis as an Unusual Presentation in an Anti-Aquaporin 4-Positive Patient.

Cerebrospinal fluid aquaporin‐4‐immunoglobulin G disrupts blood brain barrier

Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures

Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate

Testing for antibodies to human aquaporin-4 by ELISA: Sensitivity, specificity, and direct comparison with immunohistochemistry

Characteristics of Susac syndrome: a review of all reported cases

Update on Susac Syndrome: New Insights in Brain and Retinal Imaging and Treatment Options

Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy

Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder

Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum

Intrathecal Antibody Production Against Epstein-Barr, Herpes Simplex, and Other Neurotropic Viruses in Autoimmune Encephalitis

Retinal pathology in Susac syndrome detected by spectral-domain optical coherence tomography